| Time |
Title |
|
Slides |
|
9.00am
|
Arrival, Registration, Coffee & Tea
|
|
|
|
9.45am
|
Chairman's Welcome & Introduction
|
Allan Karr Chairman, PDIG
|
|
|
10.00am
|
Pharma Industry and NHS Relations - Can we work together? - What is the new guidance on joint working?
- Can the Industry survive PPRS?What are the key drivers for change?
|
David Fisher ABPI, Commercial Director
|
View Slides
|
|
10.45am
|
Risk Management or Patient Access Programmes - are the views of Pharma and Practitioners the same? - What are the strategic issues driving risk sharing schemes?
- How do the key stakeholders view the schemes?
Do risk sharing schemes work?
|
Dr Rafiq Hassan, Head of Market Access, juneartis Kevan Wind, Medicines Procurement Specialist Pharm
|
View Slides
|
|
11.30am
|
Tea/Coffee
|
|
|
|
12 Noon
|
A Review of the Supply Chain Model - What is happening to the supply chain?
- Who are the winners and losers?
- What will the supply chain look like in the future?
|
Michael Thomas Principal, A.T. Kearney Ltd
|
View Slides
|
|
12.45pm
|
David Samways Award
|
|
|
|
12.50pm
|
Lunch
|
|
|
|
2.00pm
|
How do Pharma set the prices of their medicines?
- What factors influence the cost of medicines?
- Do we get value from the cost of our medicines?
- Why do Orphan medicines cost so much?
|
Donald Macarthur Indepenent Consultant
|
View Slides
|
|
2.45pm
|
Purchasing new products to assist implementation of NPSA injectable guidance
- What factors influence the cost of medicines?
- Do we get value from the cost of our medicines?
- Why do Orphan medicines cost so much?
|
Dr Clare Crowley Medicines Safety Pharmacist, Oxford Radcliffe Hosp
|
View Slides
|
|
3.15pm
|
The Chain Reaction
- Pandemic flu – myth or reality?
- How will the supply chain cope?
- What are key strategic measures that will affect the whole supply chain?
|
Michael Young Medicines, Pharmacy, Industry Dept (MPI), DoH
|
View Slides
|
|
4.00pm
|
Close
|
|
|